Medication adherence to injectable glucagon-like peptide-1 (GLP-1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta-analysis.

Erin R WeedaAlyssa K MuraokaMatthew D BrockJessica M Cannon

Published in: International journal of clinical practice (2021)

Once weekly dosing of injectable GLP-1RAs was associated with better adherence vs once daily dosing among patients with T2D. These findings coupled with the known detrimental consequences of non-adherence suggest that dosing frequency is an important factor to consider when selecting a GLP-1RA.

Keyphrases

physical activity
hyaluronic acid
rheumatoid arthritis
tissue engineering
glycemic control
ankylosing spondylitis
skeletal muscle
wild type
interstitial lung disease
weight loss